The Bill & Melinda Gates Foundation and Wellcome will provide $550 million for a phase 3 trial of a vaccine to prevent tuberculosis.
The pooled proportion of cases treated successfully was 44%, well below the WHO target success rate of 75%.
The authors say the oral BPaL regimen has "transformed" treatment for drug-resistant tuberculosis.
Ahead of a UN meeting, the executive director of the Stop TB Partnership discusses why the world hasn't done more to combat tuberculosis, and why she's hopeful for the future.
Screening frequency could range from one-time only screening among people at low risk for tuberculosis exposure to annual screening among those at continued risk.
To mark the observance, there were useful status reports and news of a high-level group that will lead a stronger push against TB in high-burden countries.
The rise follows a decline earlier in the pandemic, which may have contributed to delayed or missed diagnoses.
A collaboration between NGOs and a diagnostic test maker will provide rapid molecular TB tests to high-burden countries at a reduced price.
In a randomized trial conducted in five countries, a 2-month drug regimen was found to be non-inferior to the standard 6-month treatment.
Also, Shionogi announces that the novel antibiotic cefiderocol is now available in Denmark for treating infections caused by gram-negative bacteria in patients with limited treatment options.